Manufacturing, Packaging, Labelling and Distribution of the Investigational Medicinal Product (Imp) for the Option-DM Trial (Optimal Pathway for Treating Neuropathic Pain in Diabetes Mellitus Trial)
What the buyer wrote
Text to be corrected in the original notice: Place of text to be modified: Time limit for receipt of tenders Instead of: Read: Other additional information: The contracting authority considers that this contract may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement. INVITATION TO TENDER FOR THE: PROVISION OF MANUFACTURING, PACKAGING, LABELLING AND DISTRIBUTION OF THE INVESTIGATIONAL MEDICINAL PRODUCT (IMP) FOR THE OPTION-DM TRIAL (OPTIMAL PATHWAY FOR TREATING NEUROPATHIC PAIN IN DIABETES MELLITUS TRIAL)
Details
- What the buyer calls it
- Manufacturing, Packaging, Labelling and Distribution of the Investigational Medicinal Product (Imp) for the Option-DM Trial (Optimal Pathway for Treating Neuropathic Pain in Diabetes Mellitus Trial)
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 21 Oct 2016
- Work ends
- 21 Apr 2019
- Kind of work
- Professional services, Logistics, courier and distribution
Who the buyer named
The buyer published a contact address on this notice.
